As the latest edition of the Bayley Scales (Bayley-III) produces higher scores than its predecessor (BSID-II), there is uncertainty about how to classify moderate-severe neurodevelopmental delay. We have investigated agreement between classifications of delay made using the BSID-II and Bayley-III. Methods: BSID-II Mental Development Index (MDI) and Bayley-III cognitive and language scales were administered in 185 extremely preterm (<27 wk) children. A combined Bayley-III score (CB-III) was computed. Agreement between delay classified using MDI scores <70 and various Bayley-III cut-offs was assessed. results: Bayley-III cognitive and language scores were close to the normative mean and were higher than BSID-II MDI scores. Nineteen (10.2%) children had MDI <70. Bayley-III scores <70 significantly underestimated the proportion with MDI <70. Bayley-III cognitive and language scores <85 had 99% agreement with MDI <70 and underestimated delay by 1.1%. CB-III scores <80 had 98% agreement and produced the same proportion with delay. conclusion: Bayley-III cognitive and language scores <85 or CB-III scores <80 provide the best definition of moderatesevere neurodevelopmental delay for equivalence with MDI <70. CB-III scores have the advantage of producing a single continuous outcome measure but require further validation. The relative accuracy of both tests for predicting long-term outcomes requires investigation.
t he Bayley Scales are the most frequently used tests in infant developmental assessment. The second edition of the test, the BSID-II (1), was widely used as an outcome measure in epidemiological studies and randomized controlled trials of infant interventions. The sound psychometric properties of the BSID-II Mental Development Index (MDI), a composite measure of nonverbal cognitive and language development, engendered much professional confidence and the MDI rapidly became the gold standard for assessing neurodevelopmental outcome (2) .
In 2006, the third edition, the Bayley-III (3), was published which has separate cognitive and language scales. Although strong correlations are reported between MDI scores and Bayley-III cognitive and language scores (4, 5) , concerns have arisen over how to interpret test scores. Bayley-III scores are up to 10 points higher than MDI scores (3) (4) (5) (6) . Mean scores of control groups are of a similar magnitude above the normative mean (7, 8) and those of clinical populations are higher than anticipated (4, 5, 8) . Thus there is concern that the Bayley-III underestimates developmental delay using conventional cut-offs (4, 6, (8) (9) (10) (11) . However, as yet it is not clear whether the Bayley-III underestimates developmental delay or the BSID-II overestimated it.
These issues have significant implications for research and clinical practice. Children with developmental problems may not be identified using the Bayley-III and may thus fail to be referred for intervention. For research, the underestimation of delay leads to reduced statistical power in randomized controlled trials where sample sizes have been calculated using prevalence estimates obtained from studies using the MDI. Some groups have opted to raise Bayley-III SD-banded cut-offs by 15-points (1 SD) to retain power for primary outcomes and to identify children in need of intervention (12) . It has also been suggested that raising the cut-off by 10-points maximizes agreement with the MDI (5). However, there still remains the problem of how to use Bayley-III scores to provide a relevant and practical composite outcome for identifying delay in research (13) . To address these issues, we have investigated the predictive value of different Bayley-III cut-offs for classifying neurodevelopmental delay as measured by the BSID-II MDI in children born extremely preterm. Table 1 . The mean MDI score (93; SD 18) was 7-points lower than the normative mean and 19 (10.2%) children had neurodevelopmental delay. Mean Bayley-III scores were considerably higher and were close to the normative mean (cognitive 96, SD 14; language 103, SD 19; CB-III 100, SD 16). Bayley-III cognitive, language and CB-III scores were 3, 10, and 7 points higher than MDI scores, respectively. These results and correlations between test scores have been published previously (5) . Using conventional SD-banded cut-offs, Bayley-III scores resulted in fewer children with
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Articles moderate-severe delay and 10-14% more children in the average range ( Table 1) . Table 2 shows the proportion of children with moderatesevere neurodevelopmental delay measured by the MDI and Bayley-III cut-offs. All Bayley-III scores <70 under-estimated the prevalence of delay by 2-7%; this difference was statistically significant for cognitive scores, cognitive and language scores and CB-III scores <70. Using Bayley-III scores <80, CB-III scores identified the same proportion with delay whilst cognitive scores alone and cognitive and language scores <80 significantly under-estimated the prevalence of delay. Taking scores <85, the proportion of children identified with delay using cognitive or cognitive and language scores differed by only 0.5-1.1%; however, language, CB-III and cognitive or language scores <85 significantly over-estimated the proportion with delay ( Table 2) .
Although the proportion of children with moderate-severe neurodevelopmental delay may be similar, this is not sufficient to determine the best cut point as agreement may be poor at the individual level. Predictive values were therefore calculated to assess diagnostic utility of the Bayley-III ( Table 3 ). There were only marginal differences with the greatest agreement being for cognitive and language scores <85 (99% agreement) and CB-III scores <80 (98% agreement). In general, classifications with the poorest agreement were Bayley-III scores <70; cognitive and language scores <70 had poor sensitivity resulting in only 32% of children with MDI<70 being detected as delayed using the Bayley-III; sensitivity was 42% and 58% respectively for Bayley-III cognitive and language scores <70.
DISCUSSION
The results of this study show that, when using the Bayley-III to measure neurodevelopmental delay, classifications of cognitive and language scores <85 or CB-III scores <80 have the highest agreement with MDI scores <70 from the previous edition. These cut-offs resulted in a similar prevalence of children with neurodevelopmental delay and afforded the best prediction of an MDI <70 at the individual level.
There were only marginal differences in the predictive value of the various Bayley-III cut-offs assessed. All those in which cognitive and language scores were combined had >95% agreement. Such levels are to be expected where both tests measure the same underlying constructs. Selecting the most appropriate Bayley-III cut-off is therefore a pay-off between optimising the accuracy of prevalence estimates and the identification of delay at the individual level. Although cognitive and language scores <85 classified almost all children with delay who had MDI <70 (99%), it under-identified delay by 1.1%. In comparison, CB-III scores produced an identical prevalence estimate and were only 1.08% less accurate in their agreement. The differences are so subtle that these cut-offs may be used interchangeably when categorizing outcomes, and both will improve statistical power for primary outcomes compared with conventional SD-banded cut-offs. CB-III scores have an added advantage however, in providing a single continuous outcome measure.
Although there were only marginal differences between the cut-offs explored, Bayley-III scores <70 significantly underestimated the prevalence of MDI <70. This was expected as, although there are moderate to strong correlations between MDI and Bayley-III scores (3) (4) (5) , there is poor agreement between the two tests and scores are off-set by around 3-7 points. Of most concern is that this difference is not linear resulting in greater differences in scores at the lower end of the scale (5,7). This has major implications for clinical populations, to whom the test is most frequently applied, in terms of reduced prevalence estimates for neurodevelopmental delay and under-identification of children in need of intervention. Randomized studies of developmental care and parenting interventions have produced mixed results, but there appears to be benefits in terms of improved neurodevelopmental outcomes over infancy and the preschool years (14, 15) . If such improvements can be assured then the early identification of extremely preterm children in need of intervention is crucial, for which well-standardized developmental tests with appropriate cut-offs need to be applied. We believe that the results of this study will provide clinicians with information to aid in the interpretation of Bayley-III scores for these purposes.
Whether the Bayley-III underestimates developmental delay or the BSID-II MDI overestimated it remains an open question. However, converging evidence suggests the former as the present population, are anchored around the normative mean, and mean scores for normative control groups are higher than the norm (5, 8) . It is plausible that the Bayley-III underestimates developmental delay since 10% of children in the standardization sample had established developmental problems. This proportion far exceeds that of the normal distribution and questions the validity of the standardization sample as a normative reference (3). Over-sampling of children with developmental problems ultimately has the effect of making the test "easier" and provides a mechanism whereby 
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Articles the Bayley-III may lead to under-estimation of developmental delay (18) . Further support is provided by a recent study in which a Bayley-III cognitive score <80 at 22 mo had the best prediction of an IQ score <70 at 3 y of age in very preterm children (D.E. Creighton, S. Tang, J.E. Newman, A. Holub, R. Sauve, unpublished data). However, this was not compared with the MDI or the predictive validity of other Bayley-III scores assessed. To address this question definitively longitudinal studies are needed to determine the relative predictive validity of both editions of the test. This is the largest study to date in which the BSID-II and Bayley-III has been administered in the same sample permitting a direct comparison of scores on both tests. The methodology used ensured that children's performance on all items on both tests was directly assessed, rather than estimated. As children who could not complete the two tests in succession were excluded the prevalence of moderate-severe neurodevelopmental delay in our extremely preterm children is actually higher than reported here. However, this does not negate the validity of our findings since the aim of this study was to compare the relationship between the two tests in the same group of children rather than assess neurodevelopmental outcomes. Exploring these issues in an extremely preterm cohort in which neurodevelopmental problems are common was fortuitous in highlighting the nonlinear off-set in scores (5). However, caution should be observed before applying these findings to other populations. Future studies should aim to replicate the current findings in other large clinical populations, such as infants born at more mature preterm gestations, and at different ages of assessment. Exploration of these issues in community-based samples and in larger samples of children with developmental delay would improve the power of future studies and are needed to determine the most appropriate cut-off for identifying long-term developmental problems.
Given the potential for improved clinical utility of the Bayley-III for identifying profiles of abilities across separable domains, future research is needed to address the psychometric properties of the test in response to examiners' concerns and to identify more appropriate clinical, and potentially population-specific, cut-off points. This should include an exploration of the psychometric properties of CB-III scores for identifying concurrent delays and predicting future outcomes. Crucially, the relative accuracy of BSID-II MDI and Bayley-III cut-offs for predicting long-term outcomes requires investigation in order to determine whether the MDI overestimates or the Bayley-III underestimates neurodevelopmental delay. The agreement between classifications of delayed motor development measured using both tests also requires investigation. The present findings should be only applied to Bayley-III motor scale scores with caution before such studies have been conducted.
Conclusions
To identify moderate-severe developmental delay and provide sufficient power for primary outcomes, Bayley-III cognitive and language scores <85 or CB-III scores <80 provide the best correspondence with MDI scores <70. Using CB-III scores has the added advantage of producing a single continuous outcome measure; future studies should therefore explore the psychometric properties of these scores. Follow-up of this cohort is needed to determine the accuracy of the Bayley-III for predicting long-term cognitive outcomes.
METHODS
Participants
All babies born 22-26 wk of gestation in England in 2006 and who survived to discharge were invited to participate in a follow-up assessment at 2-3 y of age corrected for prematurity (19) . Of those alive at 2.5 y, 576 (55.3%) were formally assessed at 27-48 mo corrected age. In 225 (39.1%) children who were free of major neurosensory impairment and whose first language was English, an examiner administered the BSID-II MDI and the Bayley-III cognitive and language scales. Of these, 40 (18%) children were unable to cooperate for the time required to complete both tests. Thus, data from 185 children aged 29-41 mo corrected age (median 33 mo; median gestational age 25 wk, range 22-26 wk; 90 (40%) males) were included in the present study (Figure 1) . Parents provided informed consent and the study was approved by the Northern and Yorkshire Research Ethics Committee.
Procedure and Measures
The cognitive and language scales of the Bayley-III were administered first and overlapping MDI items were scored simultaneously. Additional MDI item were administered after the Bayley-III. Examiners had >95% agreement with an experienced developmental psychologist across item scores on both Bayley-III scales indicating excellent inter-rater reliability. The protocol for this study has been published previously (5) . The BSID-II MDI comprises items to assess cognitive and language development and yields a single age-standardized score (mean 100; SD 15; range 50-150). Children with scores below the basal limit were assigned a nominal score of 49 to reflect severely delayed development (20) . The Bayley-III yields separate scores for cognitive (mean 100; SD 15; range 55-155) and Language (mean 100; SD 15; range 45-155) Scales. Extrapolated norms were used to quantify development for scores <55 on the cognitive scale (21) . A CB-III score was calculated using the average of the child's cognitive and language scores. To classify moderate-severe neurodevelopmental delay on the criterion measure, the conventional cut-off of MDI scores <70 Figure 1 . Participant recruitment and final study sample. MDI, Mental Development Index.
Alive at discharge n = 1,041
Developmental test at 2.5 y n = 576
Bayley-III completed n = 501
Not formally assessed n = 465
Bayley-III not complete n = 69
Bayley-III part complete n = 10 Other test used n = 39 Severely impaired n = 20
Not English/impaired/ assessor not trained n = 276
Unable to cooperate n = 40
Local assessment only n = 191 Died prior to 2.5 y n = 10 Refused/lost contact n = 264
